North America Peptide Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (Generic, Innovative); Route of Administration (Parenteral, Oral, Mucosal, Pulmonary, Others); Synthesis Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), Hybrid Technology); Application (Cancer, Cardiovascular Disorder, Metabolic Disorder, Respiratory Disorder, Pain, Dermatology), and Country

Market Introduction

A patient portal is an online application that enables the maintenance of the data of patients. The patient portal is a web-based solution connected with electronic health records and allows patients to access their health records. The patients can share their health information and communicate remotely.

Get more information on this report :

Market Overview and Dynamics

The North America peptide therapeutics market is expected to reach US$ 20,381.28 million by 2027 from US$ 9,998.34 million in 2019; it is estimated to grow at a CAGR of 9.4% from 2020 to 2027. The growth of the North America peptide therapeutics market is attributed to key driving factors, such as growing investments in peptide therapeutics and increasing prevalence of metabolic disorders and infectious diseases. However, operational limitations of peptides are expected to restrain the growth of the market during the forecast period.

Key Market Segments

Based on type, the North America peptide therapeutics market is segmented into generic and innovative. The innovative segment held the largest share of the market in 2019, whereas the generic segment is anticipated to register the highest CAGR in the market during the forecast period.

In terms of route of administration, the North America peptide therapeutics market is segmented into parenteral, oral, mucosal, pulmonary, and others. The parenteral segment held the largest share of the market in 2019, however, the oral segment is anticipated to register the highest CAGR in the market during the forecast period.

Based on synthesis technology, the North America peptide therapeutics market is segmented into solid phase peptide synthesis (SPPS), liquid phase peptide synthesis (LPPS), and hybrid technology. The solid phase peptide synthesis segment held the largest share of the market in 2019. The hybrid technology segment is anticipated to register the highest CAGR in the market during the forecast period.

Based on application, the North America peptide therapeutics market is segmented into cancer, cardiovascular disorder, metabolic disorder, respiratory disorder, pain, and dermatology. The cancer segment held the largest share of the market in 2019. The metabolic disorder segment is estimated to register the highest CAGR in the market during the forecast period.

Major Sources and Companies Listed

A Few of the primary and secondary sources associated with this report on the North America peptide therapeutics market are the Centers for Disease Control and Prevention (CDC), Canadian Institutes of Health Research (CIHR) and International Diabetes Federation (IDF).

Reasons to buy the report

Determine prospective investment areas based on a detailed trend analysis of the North America peptide therapeutics market over the next years.
Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
Identify the major channels driving the North America peptide therapeutics market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
Channelize resources by focusing on the ongoing programs undertaken by the different countries within the North America peptide therapeutics market.

NORTH AMERICA PEPTIDE THERAPEUTICS SEGMENTATION

By Type

Innovative
Generic

By Route of Administration

Parenteral
Mucosal
Oral
Pulmonary
Others

By Synthesis Technology

Solid Phase Peptide Synthesis (SPPS)
Liquid Phase Peptide Synthesis (LPPS)
Hybrid Technology

By Application

By Country

US
Canada
Mexico

Company Profiles

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Peptide Therapeutics Market – By Type

1.3.2 North America Peptide Therapeutics Market – By Route of Administration

1.3.3 North America Peptide Therapeutics Market – By Synthesis Technology

1.3.4 North America Peptide Therapeutics Market – By Application

1.3.5 North America Peptide Therapeutics Market – By Country

2. Peptide Therapeutics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Peptide Therapeutics – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.3 Expert Opinion

5. Peptide Therapeutics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Investments on Peptide Therapeutics

5.1.2 Increasing Prevalence of Metabolic Disorders and Infectious Diseases

5.2 Market Restraints

5.2.1 Operational Limitations of Peptides

5.3 Market Opportunities

5.3.1 Strong Pipeline and Applications of Peptide Drugs

5.4 Future Trends

5.4.1 Emphasis on Automatic Peptide Synthesis

5.5 Impact Analysis

6. Peptide Therapeutics Market – North America Analysis

6.1 North America Peptide Therapeutics Market Revenue Forecast and Analysis

7. Peptide Therapeutics Market Analysis – By Type

7.1 Overview

7.2 Peptide Therapeutics Market Revenue Share, by Type (2019 and 2027)

7.3 Generic

7.3.1 Overview

7.3.2 Generic: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

7.4 Innovative

7.4.1 Overview

7.4.2 Innovative: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8. Peptide Therapeutics Market Analysis – By Route of Administration

8.1 Overview

8.2 Peptide Therapeutics Market Revenue Share, by Route of Administration (2019 and 2027)

8.3 Parenteral

8.3.1 Overview

8.3.2 Parenteral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8.4 Oral

8.4.1 Overview

8.4.2 Oral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8.5 Mucosal

8.5.1 Overview

8.5.2 Mucosal: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8.6 Pulmonary

8.6.1 Overview

8.6.2 Pulmonary: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8.7 Others

8.7.1 Overview

8.7.2 Others: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

9. Peptide Therapeutics Market Analysis – By Synthesis Technology

9.1 Overview

9.2 Peptide Therapeutics Market Revenue Share, by Synthesis Technology (2019 and 2027)

9.3 Solid Phase Peptide Synthesis (SPPS)

9.3.1 Overview

9.3.2 Solid Phase Peptide Synthesis (SPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

9.4 Liquid Phase Peptide Synthesis (LPPS)

9.4.1 Overview

9.4.2 Liquid Phase Peptide Synthesis (LPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

9.5 Hybrid Technology

9.5.1 Overview

9.5.2 Hybrid Technology: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

10. Peptide Therapeutics Market– Application

10.1 Overview

10.2 Peptide Therapeutics Market Share, Application, 2019 and 2027 (%)

10.3 Cancer

10.3.1 Overview

10.3.2 Cancer: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

10.4 Cardiovascular Disorders

10.4.1 Overview

10.4.2 Cardiovascular Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

10.5 Metabolic Disorder

10.5.1 Overview

10.5.2 Metabolic Disorder: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

10.6 Respiratory Disorders

10.6.1 Overview

10.6.2 Respiratory Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

10.7 Pain

10.7.1 Overview

10.7.2 Pain: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

10.8 Dermatology

10.8.1 Overview

10.8.2 Dermatology: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

11. Peptide Therapeutics Market – North America Analysis

11.1 North America: Peptide Therapeutics Market

11.1.1 Overview

11.1.2 North America: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.3 North America: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

11.1.4 North America: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.5 North America: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

11.1.6 North America: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

11.1.7 North America: Peptide Therapeutics Market, by Country, 2019& 2027 (%)

11.1.8 US: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.1 US: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.2 US: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

11.1.8.3 US: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.8.4 US: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

11.1.8.5 US: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

11.1.9 Canada: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.1 Canada: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.2 Canada: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

11.1.9.3 Canada: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.9.4 Canada: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

11.1.9.5 Canada: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

11.1.10 Mexico: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.1 Mexico: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.2 Mexico: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)

11.1.10.3 Mexico: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)

11.1.10.4 Mexico: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)

11.1.10.5 Mexico: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)

12. Impact of COVID-19 Pandemic on North America Peptide Therapeutics Market

12.1 North America: Impact Assessment of COVID-19 Pandemic

13. Company Profiles

13.1 Amgen Inc.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Eli Lilly and Company

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 EVER Pharma GmbH

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Polypeptide Group

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 TEVA PHARMACEUTICAL INDUSTRIES LTD

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 AstraZeneca

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Bristol-Myers Squibb Company

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 GlaxoSmithKline plc.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Novo Nordisk A/S

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Sanofi

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 2. North America Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 3. North America Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

Table 4. North America Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 5. US Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 6. US Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 7. US Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

Table 8. US Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9. Canada Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 10. Canada Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 11. Canada Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

Table 12. Canada Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 13. Mexico Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 14. Mexico Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 15. Mexico Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)

Table 16. Mexico Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 17. Glossary of Terms, Peptide Therapeutics Market

LIST OF FIGURES

Figure 1. Peptide Therapeutics Market Segmentation

Figure 2. Peptide Therapeutics Market Segmentation, By Region

Figure 3. North America Peptide Therapeutics Market Overview

Figure 4. Innovative Segment Held Largest Share of Peptide Therapeutics Market

Figure 5. North America Peptide Therapeutics Market – Leading Country Markets (US$ Million)

Figure 6. North America PEST Analysis

Figure 7. Peptide Therapeutics Market Impact Analysis of Drivers and Restraints

Figure 8. North America Peptide Therapeutics Market – Revenue Forecast and Analysis – 2019- 2027

Figure 9. Peptide Therapeutics Market Revenue Share, by Type (2019 and 2027)

Figure 10. Generic: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11. Innovative: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12. Peptide Therapeutics Market Revenue Share, by Route of Administration (2019 and 2027)

Figure 13. Parenteral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14. Oral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15. Mucosal: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16. Pulmonary: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17. Others: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18. Peptide Therapeutics Market Revenue Share, by Synthesis Technology (2019 and 2027)

Figure 19. Solid Phase Peptide Synthesis (SPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20. Liquid Phase Peptide Synthesis (LPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21. Hybrid Technology: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22. Peptide Therapeutics Market Share, Application, 2019 and 2027 (%)

Figure 23. Cancer: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 24. Cardiovascular Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 25. Metabolic Disorder: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 26. Respiratory Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 27. Pain: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 28. Dermatology: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 29. North America: Peptide Therapeutics Market, by Key Country – Revenue (2019) (USD Million)

Figure 30. North America Peptide Therapeutics Market Revenue and Forecast to 2027 (USD Million)

Figure 31. North America: Peptide Therapeutics Market, by Country, 2019 & 2027 (%)

Figure 32. US: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 33. Canada: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 34. Mexico: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 35. Impact of COVID-19 Pandemic in North America Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America peptide therapeutics market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the North America peptide therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample